These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11130325)
1. Part VI. Primary drug therapies for Alzheimer's disease. Knopman DS Dis Mon; 2000 Nov; 46(11):745-60. PubMed ID: 11130325 [No Abstract] [Full Text] [Related]
2. Treatment of Alzheimer's disease. New developments. Giacobini E; Michel JP Ann Med Interne (Paris); 1998 Jun; 149(4):231-7. PubMed ID: 11490551 [TBL] [Abstract][Full Text] [Related]
3. [Memory mechanisms and expectancy of therapy in Alzheimer's disease]. Vetulani J Neurol Neurochir Pol; 2000; 34(3):429-46. PubMed ID: 10979538 [No Abstract] [Full Text] [Related]
4. New therapies. New Alzheimer's treatments that may ease the mind. Helmuth L Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764 [No Abstract] [Full Text] [Related]
5. Alzheimer's disease: the search for causes and treatments--Part II. Harv Ment Health Lett; 1998 Sep; 15(3):1-5. PubMed ID: 9723017 [No Abstract] [Full Text] [Related]
6. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
7. Combination drug therapies for AD: progress is slow, but we must keep trying. Farlow MR Geriatrics; 2005 Jun; 60(6):13-4. PubMed ID: 15948660 [No Abstract] [Full Text] [Related]
8. Muscarinic M(1) agonists in the treatment of Alzheimer's disease. Korczyn AD Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: a progress report. How far the search for treatments has come and where it is heading. Harv Ment Health Lett; 2003 Nov; 20(5):1-4. PubMed ID: 14633486 [No Abstract] [Full Text] [Related]
10. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease. Senin U; Cherubini A; Palumbo B; Mecocci P Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980 [No Abstract] [Full Text] [Related]
11. Combination therapy for early Alzheimer's disease: what are we waiting for? Doraiswamy PM; Steffens DC J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922 [TBL] [Abstract][Full Text] [Related]
12. Neuropathology in Alzheimer's disease: target of pharmacotherapy. Souder E J Am Acad Nurse Pract; 2005 Mar; Suppl():3-5. PubMed ID: 16033022 [TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. Farías GG; Godoy JA; Vázquez MC; Adani R; Meshulam H; Avila J; Amitai G; Inestrosa NC Neurobiol Dis; 2005 Feb; 18(1):176-83. PubMed ID: 15649708 [TBL] [Abstract][Full Text] [Related]